Avelumab User Reviews & Ratings
Brand names: Bavencio
Avelumab has an average rating of 9.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Renal Cell Carcinoma | 1 reviews for Renal Cell Carcinoma | 23 medications |
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about avelumab
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
For Renal Cell Carcinoma "I have been getting Avelumab infusions for 4 years. The drug has minimal side effects, primarily some itching periodically. I am in a clinical trial with a subsidiary of Merck in Germany. Just entered a rollover clinical trial where the observation period of 2 hours is being eliminated as I have shown no adverse effects in 4 years. My overall strength is good. Play golf 2 times a week and with solid energy to play as well as ever. So far, very happy with the therapy from Avelumab infusions. Most tumors have decreased or disappeared. However, one in my stomach remains pretty constant but does not weaken me in any way. Hopefully, it will eventually go away. Would recommend this treatment."